GTHX stock forecast
Our latest prediction for G1 Therapeutics Inc's stock price was made on the Jan. 4, 2024 when the stock price was at 3.10$.
In the short term (2weeks), GTHX's stock price should underperform the market by -2.39%. During that period the price should oscillate between -10.08% and +7.17%.
In the medium term (3months), GTHX's stock price should underperform the market by -2.33%. During that period the price should oscillate between -31.20% and +16.21%.
Get email alertsCreate a solid portfolio with GTHX
About G1 Therapeutics Inc
g1 therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. the company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.30$ per share.
The book value per share is 5.28$
Three months stock forecastJan. 4, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -61M | - | -77M | -1.30 | - | - | 51M | 5.28 | - | - | - |